REFERENCES
- Passey R. D. Experimental soot cancer. Br. Med. J. 1922; ii: 112–113
- Pott P. Chirurgical Observations Relative tothe Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the DifferentKinds of Ruptures and the Mortifications of the Toes and Feet. Hawes, Clarkeand Collins, London 1775
- Tomatis L. The predictive value of rodent carcinogenicity tests in theevaluation of human risk. Annu. Rev. Pharmacol. Toxicol. 1979; 19: 511–530
- Huff J. Chemicals and cancer in humans: First evidence in experimentalanimals. Environ. Health Perspect. 1993; 100: 201–210
- Bradford A. Hill. The environment and disease: Association or causation. Proc. Roy. Soc. Med. 1965; 56: 295–300
- Bradford A. Hill. Principles of Medical Statistics. The Lancet Ltd, London 1971
- Rothman K. J. Modern Epidemiology. Little, Brown & Co., Boston 1986
- Tomatis L., Huff J., Hertz-Picciotto I., Sandler D. P., Bucher J., Boffetta P., Axelson O., Blair A., Taylor J., Stayner L., Barrett J. C. Avoided and avoidable risks of cancer. Carcinogenesis 1997; 18: 97–105
- Higginson J. DDT: Epidemiological evidence. Interpretation of Negative Epidemiological Evidence for Carcinogenicity, N. J. Wald, R. Doll. IARC, Lyon 1985; 107–117
- Hueper W. C., Conway W. D. Chemical Carcinogenesis and Cancers, Charles C Thomas. Springfield, , IL 1964
- World Health Organization (WHO). Prevention of Cancer. WHO, Geneva 1964
- IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. IARC, Lyon 1972–1999; 1–71
- NTP. Eighth Report on Carcinogens. National Toxicology Program, Research TrianglePark, , NC 1998
- Huff J. E. NTP report on carcinogens: History, concepts, procedures, processes. Eur. J. Oncol. 1998; 3: 343–355
- Mechanisms of Carcinogenesis in Risk Identification, H. Vainio, P. Magee, D. McGregor, A. J. McMichael. IARC, Lyon 1999
- IARC Monograph on the Evaluation of Carcinogenic Risk to Humans, Preamble. Occupational Exposures to Mists and Vapors from Strong InorganicAcids. IARC, Lyon 1954; 54
- Melnick R. L., Kohn M. C., Huff J. Weight of evidence versus weight of speculation to evaluatethe alfa2u-globulin hypothesis. Environ. Health Perspect. 1997; 105: 904–906
- Capen C. C., Dybing E., Rice J. M., Wilbourn J. D. Species Differences in Thyroid, Kidney and Urinary Bladder Carcinogenesis. IARC, Lyon 1999
- Environmental Protection Agency (EPA), Proposed guidelines forcarcinogen risk assessment, notice of availability and opportunity to commenton proposed guidelines for carcinogenic risk assessment. Fed. Reg. 1996; 61: 17,959–18,011
- Karstadt M., Haseman J. K. Effect of discontinuing certain tumor types/sites on evaluationsof carcinogenicity in laboratory animals. Am. J. Ind. Med. 1997; 31: 485–494
- Karstadt M., Bobal R., Selikoff I. J. A survey of availability of epidemiologic data on humans exposed to animal carcinogens. Quantification of Occupational Cancer, Banbury Report No. 9, R. Peto, M. Schneiderman. ColdSpring Harbor Laboratory, Cold Spring Harbor, , NY 1981; 223–242
- Karstadt M. Availability of epidemiologic data for chemicals known to causecancer in animals: An update. Am. J. Ind. Med. 1998; 34: 519–525
- Tomatis L., Huff J. Evolution of research in cancer etiology. The Molecular Basis of Human Cancer, W. B. Coleman, G. J. Tsongalis. Humana Press, Totowa, , NJ 2000